Serial Number
86481014
Owner
ALLERGAN HOLDINGS UNLIMITED COMPANYAttorney
Maryam ArastuFirst Use Date
Dec 14, 2015
Filing Date
Dec 15, 2014
VIBERZI Trademark
Serial Number: 86481014 • Registration: 4928665
Trademark Classes
Owner Contact Info
CLONSHAUGH BUSINESS & TECHNOLOGY PARK
DUBLIN 17 , IE
Entity Type: 99
400 INTERPACE PARKWAY
PARSIPPANY, NJ 07054
Entity Type: 16
Legal Representation
Correspondence Address
Maryam Arastu AbbVie Inc.
1 N. Waukegan Road
North Chicago, IL 60064
United States
Trademark Details
Filing Date
December 15, 2014
Registration Date
March 29, 2016
First Use Anywhere
December 14, 2015
First Use in Commerce
December 14, 2015
Published for Opposition
June 9, 2015
Goods & Services
[ Oral, Transdermal, Injectable and Intravaginal Contraceptives; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; ] Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome [ ; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics, Antifungals, Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Excluding pharmaceuticals for the diagnosis and/or treatment of diabetes ]
